UP!
| 2016-03-05 | Reiterated Rating | Stephens | Buy | |
| 2015-08-12 | Lower Price Target | Dougherty & Co | Buy | $7.00 to $4.00 |
| 2015-08-11 | Downgrade | SunTrust | Buy to Neutral | $5.00 to $2.00 |
| 2015-08-11 | Downgrade | SunTrust Banks Inc. | Buy to Neutral | $5.00 to $2.00 |
| 2015-05-23 | Reiterated Rating | Barrington Research | Outperform | $7.00 to $6.00 |
| 2015-05-11 | Lower Price Target | SunTrust | Buy | $7.00 to $5.00 |
| 2015-05-08 | Lower Price Target | Jefferies Group | Buy | $8.00 to $6.50 |
| 2015-04-09 | Initiated Coverage | Craig Hallum | Buy | $7.00 |
| 2014-11-20 | Initiated Coverage | Barrington Research | Outperform | $8.00 |
| 2014-11-06 | Reiterated Rating | Jefferies Group | Buy | $11.00 to $9.50 |
| 2014-02-27 | Downgrade | Sidoti | Buy to Neutral | |
| 2014-02-04 | Reiterated | Dougherty & Company | Buy | $8 to $12 |
| 2014-02-04 | Boost Price Target | Dougherty & Co | Buy | $8.00 to $12.00 |
| 2013-11-08 | Lower Price Target | Noble Financial | Buy | $13.00 to $11.00 |
| 2013-11-08 | Downgrade | Feltl & Co. | Strong-Buy to Buy | $11.00 to $7.50 |
| 2013-09-27 | Lower Price Target | Jefferies Group | Buy | $17.00 to $11.00 |
| 2013-09-26 | Lower Price Target | Noble Financial | Buy | $16.00 to $13.00 |
| 2013-09-25 | Reiterated | Dougherty & Company | Buy | $15 to $10 |
| 2013-09-25 | Lower Price Target | Dougherty & Co | Buy | $15.00 to $10.00 |
| 2013-06-18 | Reiterated | Dougherty & Company | Buy | $15 to $20 |
| 2013-04-09 | Initiated | Feltl & Co. | Strong Buy | $15 |
| 2012-05-10 | Reiterated | Dougherty & Company | Buy | $10 to $13 |
| 2011-09-28 | Initiated | BB&T Capital Mkts | Buy | $10 |
| 2008-09-12 | Downgrade | Piper Jaffray | Buy to Neutral | |
| 2008-08-13 | Initiated | Noble Financial | Buy | $6.50 |
| 2008-05-06 | Reiterated | Broadpoint Capital | Buy | $9 to $6 |
| 2008-04-30 | Reiterated | Dougherty & Company | Buy | $15 to $8 |
| 2008-02-15 | Upgrade | Broadpoint Capital | Neutral to Buy | $9 |
| 2007-10-15 | Downgrade | Broadpoint Capital | Buy to Neutral | |
| 2007-06-28 | Upgrade | Piper Jaffray | Market Perform to Outperform | |
| 2007-05-07 | Reiterated | First Albany | Buy | $4 to $6 |
| 2016-03-05 | Reiterated Rating | Stephens | Buy | |
| 2015-08-12 | Lower Price Target | Dougherty & Co | Buy | $7.00 to $4.00 |
| 2015-08-11 | Downgrade | SunTrust | Buy to Neutral | $5.00 to $2.00 |
| 2015-08-11 | Downgrade | SunTrust Banks Inc. | Buy to Neutral | $5.00 to $2.00 |
| 2015-05-23 | Reiterated Rating | Barrington Research | Outperform | $7.00 to $6.00 |
There is presents forecasts of rating agencies and recommendations for investors about this ticker
In BIOS 59 funds of 2213 total. Show all
| Fund name | Ticker shares |
|---|---|
| BlackRock Fund Advisors | 3.04M |
| BlackRock Institutional Trust Company, N.A. | 2.14M |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 2.07M |
| Saba Capital Management, L.P. | 1.79M |
| SEVEN LOCKS CAPITAL MANAGEMENT LP | 1.34M |
| Polar Securities Inc. | 1.06M |
| LINDEN ADVISORS LP | 1.00M |
| CANTOR FITZGERALD, L. P. | 0.85M |
| GOLDMAN SACHS GROUP INC | 0.83M |
| D. E. Shaw & Co., Inc. | 0.80M |
| CNH PARTNERS LLC | 0.62M |
| Starboard Value LP | 0.62M |
| Cubist Systematic Strategies, LLC | 0.55M |
| Marshall Wace LLP | 0.50M |
| OZ MANAGEMENT LP | 0.50M |
| Name Relationship | Total Shares | Holding stocks |
|---|---|---|
| Coliseum Capital Management, LLC | 2.75% (1888991) | ACW / ADES / BIOS / HCAC / LHCG / PRSC / UTI / |
| Kohlberg Management V, LLC * See remarks below | 2.61% (1788542) | BIOS / |
| FRIEDMAN RICHARD H Chairman of the Board and CEO | 0.56% (382179) | BIOS / |
| Rosenbaum Stanley Former Officer | 0.30% (204757) | BIOS / |
| Pate R Carter | 0.24% (162405) | ADES / BIOS / PRSC / |
| SMITH RICHARD M President and CEO | 0.20% (135000) | BIOS / |
| Bronfein Michael G | 0.19% (129669) | BIOS / |
| GOLDING DAVID W | 0.17% (119169) | BIOS / |
| ROBBINS RICHARD L | 0.17% (113500) | BIOS / |
| GOLDSTEIN MICHAEL | 0.15% (105169) | BIOS / BSC / PSUN / |
| Nguyen Tricia | 0.13% (89669) | BIOS / |
| Tran Hai Chief Financial Officer | 0.11% (77944) | BIOS / |
| SAMUELS STUART A | 0.10% (66500) | BIOS / |
| COLLNS CHARLOTTE W | 0.09% (63800) | BIOS / |
| Stiver Brian Edward SVP National Infusion Sales | 0.07% (50000) | BIOS / |
| WOODWARD GORDON (see remarks below) | 0.07% (50000) | BIOS / |
| FRIEDER SAMUEL P (see remarks below) | 0.07% (50000) | BIOS / KCAP / |
| Schott Alex Senior Vice President | 0.06% (40802) | BIOS / |
| HOLUBIAK MYRON Z | 0.06% (40000) | ASMB / BIOS / MRNA / |
| DIFAZIO LOUIS DR | 0.05% (36000) | BIOS / |
| GREENLEAF DANIEL E Chief Executive Officer | 0.05% (31000) | BIOS / |
| POSNER BARRY A Executive Vice President | 0.04% (30410) | BIOS / |
| HUBERS DAVID R | 0.04% (30000) | BIOS / |
| JORDEN YON | 0.03% (20000) | BIOS / CPST / MAG / MXWL / |
| Luthin James C SVP & Chief Operating Officer | 0.02% (13802) | BIOS / |
| Kreger Jeffrey M Chief Financial Officer | 0.02% (12628) | BIOS / LHCG / |
UM